Smokers have been looking for effective ways to quit their deadly addiction to combustible cigarettes for generations.
Smoking cessation products that such as Nicorette, Chantix, and Zyban – all approved by the U.S. Food and Drug Administration (FDA) – promised hope to the tens of millions of American smokers desperately trying to lead healthier lives.
Unfortunately, those products only proved successful to a small percentage of smokers. Then a dozen years ago, a miracle occurred. Disappointed by the lack of effective options, smokers took their future into their own hands and created the modern vaping market, building their own devices and flavors in their homes and in their free time. Over the next decade, over 10 million smokers successfully quit, and a flourishing industry emerged, comprised mostly of small businesses. Unfortunately, recently the FDA ripped control of this revolutionary movement away from the victims of Big Tobacco that created it and handed over control of these life-saving products to the tobacco manufacturers.
Beginning at the end of August 2021, FDA began issuing Marketing Denial Orders (MDOs) to hundreds of innovators. With the denial, companies were required to cease production of hundreds of thousands of life-saving products used by millions of American adults nationwide. While FDA claimed that these MDOs would be limited to only the flavored products that they erroneously claim appeal to children, the majority of these companies also had their tobacco and menthol-flavored products ripped from the market as well. The limited number of manufacturers with the financial resources available to wage a litigious war with the federal government did so, and within days the FDA backed down on one particular, returning their products to the market while the scientific review process continued.
Dave Morris – Inside Sources – 2021-10-20.